minuscule 发表于 2025-3-21 19:47:03

        SCIE(SCI)期刊Endocrine Metabolic & Immune Disorders-Drug Targets(20 21 REV HIST)影响因子<br>        http://impactfactor.cn/2024/if/?ISSN=1871-5303<br><br>        SCIE(SCI)期刊Endocrine Metabolic & Immune Disorders-Drug Targets(ENDOCR METAB IMMUNE)影响因子@(内分泌学和代谢学)学科排名<br>        http://impactfactor.cn/2024/ifr/?ISSN=1871C5303<br><br>        SCIE(SCI)期刊Endocrine Metabolic & Immune Disorders-Drug Targets(20 21 REV HIST)总引论文<br>        http://impactfactor.cn/2024/at/?ISSN=1871-5303<br><br>        SCIE(SCI)期刊Endocrine Metabolic & Immune Disorders-Drug Targets(ENDOCR METAB IMMUNE)总引论文@(内分泌学和代谢学)学科排名<br>        http://impactfactor.cn/2024/atr/?ISSN=1871C5303<br><br>        SCIE(SCI)期刊Endocrine Metabolic & Immune Disorders-Drug Targets(20 21 REV HIST)影响因子<br>        http://impactfactor.cn/2024/tc/?ISSN=1871-5303<br><br>        SCIE(SCI)期刊Endocrine Metabolic & Immune Disorders-Drug Targets(ENDOCR METAB IMMUNE)总引频次@(内分泌学和代谢学)学科排名<br>        http://impactfactor.cn/2024/tcr/?ISSN=1871C5303<br><br>        SCIE(SCI)期刊Endocrine Metabolic & Immune Disorders-Drug Targets(20 21 REV HIST)即时影响因子<br>        http://impactfactor.cn/2024/ii/?ISSN=1871-5303<br><br>        SCIE(SCI)期刊Endocrine Metabolic & Immune Disorders-Drug Targets(ENDOCR METAB IMMUNE)即时影响因子@(内分泌学和代谢学)学科排名<br>        http://impactfactor.cn/2024/iir/?ISSN=1871C5303<br><br>        SCIE(SCI)期刊Endocrine Metabolic & Immune Disorders-Drug Targets(20 21 REV HIST)五年累积影响因子<br>        http://impactfactor.cn/2024/5y/?ISSN=1871-5303<br><br>        SCIE(SCI)期刊Endocrine Metabolic & Immune Disorders-Drug Targets(ENDOCR METAB IMMUNE)五年累积影响因子@(内分泌学和代谢学)学科排名<br>        http://impactfactor.cn/2024/5yr/?ISSN=1871C5303<br><br>       

业余爱好者 发表于 2025-3-21 23:35:17

Submitted on: 15 November 2020.
Revised on: 09 March 2021.
Accepted on: 07 May 2021.

___________________Endocrine Metabolic & Immune Disorders-Drug Targets

Incumbent 发表于 2025-3-22 03:23:15

http://reply.papertrans.cn/1/84/8346/8346-3.png

不容置疑 发表于 2025-3-22 07:24:26

http://reply.papertrans.cn/1/84/8346/8346-4.png

Trypsin 发表于 2025-3-22 08:58:37

http://reply.papertrans.cn/1/84/8346/8346-5.png

essential-fats 发表于 2025-3-22 15:20:50

Submitted on: 29 May 1999.
Revised on: 16 August 1999.
Accepted on: 26 September 1999.

___________________Endocrine Metabolic & Immune Disorders-Drug Targets

错 发表于 2025-3-22 18:54:27

Submitted on: 05 October 2001.
Revised on: 21 November 2001.
Accepted on: 03 December 2001.

___________________Endocrine Metabolic & Immune Disorders-Drug Targets

实现 发表于 2025-3-23 00:24:49

Submitted on: 26 April 2024.
Revised on: 29 June 2024.
Accepted on: 24 August 2024.

___________________Endocrine Metabolic & Immune Disorders-Drug Targets

搏斗 发表于 2025-3-23 05:08:10

Submitted on: 21 September 2003.
Revised on: 31 December 2003.
Accepted on: 10 February 2004.

___________________Endocrine Metabolic & Immune Disorders-Drug Targets

constitutional 发表于 2025-3-23 07:11:14

Submitted on: 11 May 1999.
Revised on: 03 June 1999.
Accepted on: 02 August 1999.

___________________Endocrine Metabolic & Immune Disorders-Drug Targets
页: [1] 2 3 4
查看完整版本: SCIE期刊Endocrine Metabolic & Immune Disorders-Drug Targets 2024/2025影响因子:2.108 (ENDOCR METAB IMMUNE) (1871-5303). (ENDOC